An improved assembly assay for peptide binding to HLA-B*2705 and H-2Kk class I MHC molecules
Identifieur interne : 001464 ( Istex/Checkpoint ); précédent : 001463; suivant : 001465An improved assembly assay for peptide binding to HLA-B*2705 and H-2Kk class I MHC molecules
Auteurs : Linda Tan [Royaume-Uni] ; Mads Hald Andersen [Danemark] ; Tim Elliott [Royaume-Uni] ; John S. Haurum [Danemark]Source :
- Journal of Immunological Methods [ 0022-1759 ] ; 1997.
English descriptors
- Teeft :
- Adenovirus, Allele, Amino acid, Anchor residues, Ankylosing spondylitis, Antigen presentation, Appropriate binding peptide, Assay, Assembly assay, Assembly assays, Binding affinity, Binding peptide, Binding peptides, Cell line, Cell lysate, Cell lysates, Cell surface, Cytotoxic, Denaturation, Elvin, Empty class, Epitope, Functional transporter, Haurum, Heat treatment, Heating step, Heavy chain, Heavy chains, High affinity, Histocompatibility, Human immunodeficiency virus, Hydrophobic residues, Idekl seil, Immunol, Immunological, Immunological methods, Influenza, Influenza matrix protein, Influenza nucleoprotein, Influenza virus, Influenza virus nucleoprotein, Lkla speler, Lysates, Lysis buffer, Major histocompatibility, Mcmichael, Molecule, Monoclonal antibodies, Murine, Murine allele, Murine polyoma virus middle, Mutant cell lines, Natural phosphorylation site, Nucleoprotein, Nucleoprotein residues, Overnight incubation, Peptide, Peptide binding, Peptide binding assay, Peptide binding motif, Peptide concentration, Peptide epitope, Peptide epitopes, Peptide motifs, Peptide presentation, Phosphorylation, Positive control, Positive control peptides, Potential novel, Protease inhibitors, Protein kinase, Protein residues, Reactive arthritis, Reliable measurements, Severe malaria, Sialic acid residues, Source protein, Stable phenotype, Such cell lines lack, Suitable peptides, Syncytial virus, Synthetic peptides, Thermal denaturation, Thermal stability, Townsend, Transgenic rats, Tryptophan residues, Unstable class, Viral peptides, Viral phosphoproteins, Virus nucleoprotein.
Abstract
Abstract: The assembly assay for peptide binding to class I major histocompatibility complex (MHC) is based on the ability to stabilise MHC class I molecules from mutant cell lines by the addition of suitable peptides. Such cell lines lack a functional transporter associated with antigen presentation (TAP) and as a result accumulate empty, unstable class I molecules in the ER. These dissociate rapidly in cell lysates unless they are stabilised by the addition of an appropriate binding peptide during lysis. The extent of stabilisation of class I molecules is directly related to the binding affinity of the added peptide. However, some MHC class I molecules, including HLA-B*2705 and H-2Kk are unusually stable in their peptide-receptive state making them inappropriate for analysis using this assay or assays which depend on the ability of peptides to stabilise MHC class I molecules at the cell surface. Here we present an improved method that permits reliable measurements of peptide binding to such class I MHC molecules that are unusually stable in the absence of peptide. Cells are lysed in the presence of peptide and incubated at 4°C. After 2 h, during which peptide binding to empty MHC molecules occurs, the lysate is heated to a temperature which preferentially destabilises those MHC molecules that remain empty. We have used this technique to assay peptide binding to HLA-B*2705, as well as to the murine allele H-2Kk which also displays a stable phenotype when transfected into TAP-deficient T2 cells and show that this method represents a marked improvement over previous methods in terms of lower background signal and higher recovery of peptide bound molecules.
Url:
DOI: 10.1016/S0022-1759(97)00142-7
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
ISTEX:A6D4925BB38A2541AA0035AA3BB812B456704254Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>An improved assembly assay for peptide binding to HLA-B*2705 and H-2Kk class I MHC molecules</title>
<author><name sortKey="Tan, Linda" sort="Tan, Linda" uniqKey="Tan L" first="Linda" last="Tan">Linda Tan</name>
</author>
<author><name sortKey="Andersen, Mads Hald" sort="Andersen, Mads Hald" uniqKey="Andersen M" first="Mads Hald" last="Andersen">Mads Hald Andersen</name>
</author>
<author><name sortKey="Elliott, Tim" sort="Elliott, Tim" uniqKey="Elliott T" first="Tim" last="Elliott">Tim Elliott</name>
</author>
<author><name sortKey="Haurum, John S" sort="Haurum, John S" uniqKey="Haurum J" first="John S" last="Haurum">John S. Haurum</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:A6D4925BB38A2541AA0035AA3BB812B456704254</idno>
<date when="1997" year="1997">1997</date>
<idno type="doi">10.1016/S0022-1759(97)00142-7</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-6H9KH91Z-L/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001E48</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001E48</idno>
<idno type="wicri:Area/Istex/Curation">001E48</idno>
<idno type="wicri:Area/Istex/Checkpoint">001464</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001464</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a">An improved assembly assay for peptide binding to HLA-B*2705 and H-2Kk class I MHC molecules</title>
<author><name sortKey="Tan, Linda" sort="Tan, Linda" uniqKey="Tan L" first="Linda" last="Tan">Linda Tan</name>
<affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>The Nuffield Department of Clinical Medicine, John Radcliffe Hospital, Oxford OX3 9DU</wicri:regionArea>
<wicri:noRegion>Oxford OX3 9DU</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Andersen, Mads Hald" sort="Andersen, Mads Hald" uniqKey="Andersen M" first="Mads Hald" last="Andersen">Mads Hald Andersen</name>
<affiliation wicri:level="1"><country xml:lang="fr">Danemark</country>
<wicri:regionArea>Institute of Cancer Biology, Danish Cancer Society, Strandboulevarden 49, 2100 Copenhagen OE</wicri:regionArea>
<wicri:noRegion>2100 Copenhagen OE</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Elliott, Tim" sort="Elliott, Tim" uniqKey="Elliott T" first="Tim" last="Elliott">Tim Elliott</name>
<affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>The Nuffield Department of Clinical Medicine, John Radcliffe Hospital, Oxford OX3 9DU</wicri:regionArea>
<wicri:noRegion>Oxford OX3 9DU</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Haurum, John S" sort="Haurum, John S" uniqKey="Haurum J" first="John S" last="Haurum">John S. Haurum</name>
<affiliation wicri:level="1"><country xml:lang="fr">Danemark</country>
<wicri:regionArea>Institute of Cancer Biology, Danish Cancer Society, Strandboulevarden 49, 2100 Copenhagen OE</wicri:regionArea>
<wicri:noRegion>2100 Copenhagen OE</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Journal of Immunological Methods</title>
<title level="j" type="abbrev">JIM</title>
<idno type="ISSN">0022-1759</idno>
<imprint><publisher>ELSEVIER</publisher>
<date type="published" when="1997">1997</date>
<biblScope unit="volume">209</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="25">25</biblScope>
<biblScope unit="page" to="36">36</biblScope>
</imprint>
<idno type="ISSN">0022-1759</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0022-1759</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Adenovirus</term>
<term>Allele</term>
<term>Amino acid</term>
<term>Anchor residues</term>
<term>Ankylosing spondylitis</term>
<term>Antigen presentation</term>
<term>Appropriate binding peptide</term>
<term>Assay</term>
<term>Assembly assay</term>
<term>Assembly assays</term>
<term>Binding affinity</term>
<term>Binding peptide</term>
<term>Binding peptides</term>
<term>Cell line</term>
<term>Cell lysate</term>
<term>Cell lysates</term>
<term>Cell surface</term>
<term>Cytotoxic</term>
<term>Denaturation</term>
<term>Elvin</term>
<term>Empty class</term>
<term>Epitope</term>
<term>Functional transporter</term>
<term>Haurum</term>
<term>Heat treatment</term>
<term>Heating step</term>
<term>Heavy chain</term>
<term>Heavy chains</term>
<term>High affinity</term>
<term>Histocompatibility</term>
<term>Human immunodeficiency virus</term>
<term>Hydrophobic residues</term>
<term>Idekl seil</term>
<term>Immunol</term>
<term>Immunological</term>
<term>Immunological methods</term>
<term>Influenza</term>
<term>Influenza matrix protein</term>
<term>Influenza nucleoprotein</term>
<term>Influenza virus</term>
<term>Influenza virus nucleoprotein</term>
<term>Lkla speler</term>
<term>Lysates</term>
<term>Lysis buffer</term>
<term>Major histocompatibility</term>
<term>Mcmichael</term>
<term>Molecule</term>
<term>Monoclonal antibodies</term>
<term>Murine</term>
<term>Murine allele</term>
<term>Murine polyoma virus middle</term>
<term>Mutant cell lines</term>
<term>Natural phosphorylation site</term>
<term>Nucleoprotein</term>
<term>Nucleoprotein residues</term>
<term>Overnight incubation</term>
<term>Peptide</term>
<term>Peptide binding</term>
<term>Peptide binding assay</term>
<term>Peptide binding motif</term>
<term>Peptide concentration</term>
<term>Peptide epitope</term>
<term>Peptide epitopes</term>
<term>Peptide motifs</term>
<term>Peptide presentation</term>
<term>Phosphorylation</term>
<term>Positive control</term>
<term>Positive control peptides</term>
<term>Potential novel</term>
<term>Protease inhibitors</term>
<term>Protein kinase</term>
<term>Protein residues</term>
<term>Reactive arthritis</term>
<term>Reliable measurements</term>
<term>Severe malaria</term>
<term>Sialic acid residues</term>
<term>Source protein</term>
<term>Stable phenotype</term>
<term>Such cell lines lack</term>
<term>Suitable peptides</term>
<term>Syncytial virus</term>
<term>Synthetic peptides</term>
<term>Thermal denaturation</term>
<term>Thermal stability</term>
<term>Townsend</term>
<term>Transgenic rats</term>
<term>Tryptophan residues</term>
<term>Unstable class</term>
<term>Viral peptides</term>
<term>Viral phosphoproteins</term>
<term>Virus nucleoprotein</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Abstract: The assembly assay for peptide binding to class I major histocompatibility complex (MHC) is based on the ability to stabilise MHC class I molecules from mutant cell lines by the addition of suitable peptides. Such cell lines lack a functional transporter associated with antigen presentation (TAP) and as a result accumulate empty, unstable class I molecules in the ER. These dissociate rapidly in cell lysates unless they are stabilised by the addition of an appropriate binding peptide during lysis. The extent of stabilisation of class I molecules is directly related to the binding affinity of the added peptide. However, some MHC class I molecules, including HLA-B*2705 and H-2Kk are unusually stable in their peptide-receptive state making them inappropriate for analysis using this assay or assays which depend on the ability of peptides to stabilise MHC class I molecules at the cell surface. Here we present an improved method that permits reliable measurements of peptide binding to such class I MHC molecules that are unusually stable in the absence of peptide. Cells are lysed in the presence of peptide and incubated at 4°C. After 2 h, during which peptide binding to empty MHC molecules occurs, the lysate is heated to a temperature which preferentially destabilises those MHC molecules that remain empty. We have used this technique to assay peptide binding to HLA-B*2705, as well as to the murine allele H-2Kk which also displays a stable phenotype when transfected into TAP-deficient T2 cells and show that this method represents a marked improvement over previous methods in terms of lower background signal and higher recovery of peptide bound molecules.</div>
</front>
</TEI>
<affiliations><list><country><li>Danemark</li>
<li>Royaume-Uni</li>
</country>
</list>
<tree><country name="Royaume-Uni"><noRegion><name sortKey="Tan, Linda" sort="Tan, Linda" uniqKey="Tan L" first="Linda" last="Tan">Linda Tan</name>
</noRegion>
<name sortKey="Elliott, Tim" sort="Elliott, Tim" uniqKey="Elliott T" first="Tim" last="Elliott">Tim Elliott</name>
</country>
<country name="Danemark"><noRegion><name sortKey="Andersen, Mads Hald" sort="Andersen, Mads Hald" uniqKey="Andersen M" first="Mads Hald" last="Andersen">Mads Hald Andersen</name>
</noRegion>
<name sortKey="Haurum, John S" sort="Haurum, John S" uniqKey="Haurum J" first="John S" last="Haurum">John S. Haurum</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Istex/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001464 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd -nk 001464 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= MersV1 |flux= Istex |étape= Checkpoint |type= RBID |clé= ISTEX:A6D4925BB38A2541AA0035AA3BB812B456704254 |texte= An improved assembly assay for peptide binding to HLA-B*2705 and H-2Kk class I MHC molecules }}
This area was generated with Dilib version V0.6.33. |